sameAs
Pressure ulcers after spinal cord injuryTHC:CBD spray and MS spasticity symptoms: data from latest studies.Management of bladder dysfunction and satisfaction of life after spinal cord injury in Norway.Long term outcome after poliomyelitis in different health and social conditions.Mortality and causes of death after traumatic spinal cord injury in Estonia.Epidemiology of persistent iatrogenic spinal cord injuries in Western Norway.Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.Cardiovascular and urological dysfunction in spinal cord injury.Traumatic spinal cord injuries--incidence, mechanisms and course.Spasticity following spinal cord injury.Cardiovascular complications of spinal cord injury.The epidemiology of injury in hang-gliding and paragliding.Management of Neuropathic Pain Associated with Spinal Cord Injury.Detection of viral sequences in archival spinal cords from fatal cases of poliomyelitis in 1951-1952.Absinthe, the nervous system and painting.Chronic pain following spinal cord injury.Acupuncture effect and omics studies.[Poliomyelitis--not an extinct disease. Outbreak of poliomyelitis in Vestlandet 1950-54]Traumatic spinal cord injury and concomitant brain injury: a cohort study.Long-term outcome after spinal cord infarctions.Traumatic spinal cord injury in two European countries: why the differences?High incidence of traumatic spinal cord injury in Estonia.Hashimoto's encephalopathy: a treatable cause of mental impairment, stroke and seizures.Diagnostic coding accuracy for traumatic spinal cord injuries.Factors influencing optimal seating pressure after spinal cord injury.Lifestyle and late effects after poliomyelitis. A risk factor study of two populations.Perceived disability, fatigue, pain and measured isometric muscle strength in patients with post-polio symptoms.Impact of fatal cases on the epidemiology of traumatic spinal cord injury in Estonia.Polio survivors--well educated and hard working.A 50-year follow-up of the incidence of traumatic spinal cord injuries in Western Norway.Post-polio syndrome and total health status in a prospective hospital study.Fatigue, pain and muscle weakness are frequent after Guillain-Barré syndrome and poliomyelitis.[Absinthe and the artistic creativeness].Telehealth for people with spinal cord injury: a narrative review.[Can poliomyelitis be eradicated in near future?].Når ryggmargen skadesMortality after traumatic spinal cord injury: 50 years of follow-upE.M. Hagen og medarbeidere svarer:Hospital based care at home; study protocol for a mixed epidemiological and randomized controlled trialBotulinum toxin treatment of spasticity targeted to muscle endplates: an international, randomised, evaluator-blinded study comparing two different botulinum toxin injection strategies for the treatment of upper limb spasticity
P50
Q26991700-B8DA6AC8-EA0B-453F-9315-38021BB6EE31Q30741239-18E3C6AD-F31C-4BC0-963B-ED91B34CD9A3Q33782238-872666D1-2DB6-45EC-986C-21EACD077D3FQ35411674-4D75C22C-C98E-4483-A8B6-8DFA69343E9BQ37317790-EA6DAA5B-5050-4A11-AC65-C09AA69CC09FQ37339758-0233C9B3-6BDA-4888-BE9D-6B34CDDC2AAAQ37737039-2B013470-EB21-4F9C-A35B-92D1EF686875Q37895319-15DD475D-B154-44B3-8DB0-4637CDC927F9Q38003321-D892FEA5-B5C0-4B68-9CEA-E09AC0F2EC14Q38007873-295D2D66-8067-435E-B61F-39F146816380Q38011980-2791D200-E677-4E3D-997F-3F1A15F81D7DQ38028744-9EA9AB00-499F-4F06-9260-48967A60A18AQ38368276-42376574-B28A-47DB-B2C4-6E86DE81968DQ38450264-5FC5DD4E-8FB9-4E62-9B3B-DE5041C93E20Q38468063-A088E096-3FCC-4D4A-89A8-3BAE2D31EC5EQ39248263-59E8CA21-3722-495A-B723-6E7EA8B2FC09Q40030278-0F87302C-5C54-4D71-982F-2F8030190377Q40655356-B653FB4B-CBD0-44DD-9C77-D8F299268D7EQ43002266-8CB973B1-7713-4FFA-9A3F-9E6DEB2F390EQ43761302-970E7E50-A93A-452A-8A4B-D9EF3E0002EDQ44317616-9B8DFF74-3848-4461-B393-B31AE20FB854Q44471963-0EFA6CD3-5398-4F24-A5AC-DD01F63774B3Q44670953-589D2B98-F950-4B5D-A995-CF2AA0EE07F8Q44780428-8BF3A5FA-C2C1-4AA0-94D3-4127D6C3DF7BQ45172704-30727FDF-C822-4185-A713-69913874B95FQ48035192-85EF4534-1A48-4F4B-B214-B14AF77322F4Q48405656-1F2937CF-FD2D-4F19-907E-48D0CF88B3FEQ50667025-63372762-2B58-4FFD-B353-128FAD711979Q50680786-CBE1A03D-8DAD-4CE0-8277-204C67AC5E56Q51137644-AF0B7C67-07C2-4754-8C5B-3A3E208B2930Q51666353-F1E16B85-A154-400E-B39C-0E2CC179EC07Q51871663-D6017D57-AE9A-40BD-9C4E-93D553DC9417Q52374627-80712CE5-4D5F-4114-98CB-6EC1E2542B04Q52668525-CF45024E-4DE8-473F-95EC-158ABE01C629Q53717429-A1720DE6-9A98-4205-AA1F-B85863F859A7Q60696656-11F320DA-90BD-4667-B00B-E766A0F05AB9Q60696658-59CD4A8F-EA0A-4F19-9589-D18CBE60345CQ60696665-3CE890E1-13DB-4E65-B6EC-67C026BAFD38Q61444860-991702B0-E1ED-4676-9D8E-AA9CDACD7C68Q64066674-92C27777-BEB2-462A-BFA0-E86DD2CD98C2
P50
description
forsker
@nb
onderzoekster uit Estland
@nl
researcher ORCID ID = 0000-0002-2506-9501
@en
name
T Rekand
@ast
T Rekand
@nl
Tiina Rekand
@da
Tiina Rekand
@de
Tiina Rekand
@en
Tiina Rekand
@es
Tiina Rekand
@et
Tiina Rekand
@fr
Tiina Rekand
@nb
Tiina Rekand
@nn
type
label
T Rekand
@ast
T Rekand
@nl
Tiina Rekand
@da
Tiina Rekand
@de
Tiina Rekand
@en
Tiina Rekand
@es
Tiina Rekand
@et
Tiina Rekand
@fr
Tiina Rekand
@nb
Tiina Rekand
@nn
altLabel
T Rekand
@es
prefLabel
T Rekand
@ast
T Rekand
@nl
Tiina Rekand
@da
Tiina Rekand
@de
Tiina Rekand
@en
Tiina Rekand
@es
Tiina Rekand
@et
Tiina Rekand
@fr
Tiina Rekand
@nb
Tiina Rekand
@nn
P214
P244
P106
P1153
6701574468
P2038
Tiina_Rekand
P21
P213
0000 0003 5981 8686
P214
P2287
P244
n2011088811
P27
P31
P496
0000-0002-2506-9501
P569
1960-11-22T00:00:00Z
P735
P7859
lccn-n2011088811